Cycuria Therapeutics is a preclinical-stage oncology startup based in Graz, Austria, founded by scientists from the Medical University of Graz, TU Munich and the University of Heidelberg. We are pioneering a novel protein-based targeted therapy for hematological cancers and beyond.
Our approach selectively targets tumor and tumor stem cells while preserving healthy hematopoiesis and overall physiology. This enables durable efficacy without dose-limiting toxicity, as demonstrated in preclinical animal models and patient-derived disease models.
By combining excellent tolerability with long-lasting efficacy, our novel therapeutic strategy aims to address significant unmet needs in cancer treatment, offering a new solution where conventional therapies have fallen short.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Stiftingtalstraße 14, Graz,styria 8010,austria
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.cycuria.com
- HQ
- Graz, Styria
Cycuria Therapeutics Questions
Cycuria Therapeutics's website is http://www.cycuria.com
Cycuria Therapeutics's LinkedIn profile is https://at.linkedin.com/company/cycuria
Cycuria Therapeutics has
7 employees.
View email and phone details for 7
employees at Cycuria Therapeutics.
Cycuria Therapeutics's industry is
Pharmaceutical Manufacturing
Cycuria Therapeutics's top competitors are
Zwt Graz,
Iomx Therapeutics Ag,
Brave Analytics Gmbh,
Kincon Biolabs,
Mpl-Mikrobiologisches Prüflabor Gmbh,
Biotech Austria,
Enzyan Biocatalysis Gmbh,
Simvantage,
Kamosys,
Cbmed Gmbh.
Cycuria Therapeutics's categories are Pharmaceutical Manufacturing
Cycuria Therapeutics's founding year is 2024
